Beyond Opioids for Pain Management in Adult Critically Ill Patients

J Pharm Pract. 2019 Jun;32(3):256-270. doi: 10.1177/0897190019834479. Epub 2019 Mar 7.

Abstract

Critically ill patients commonly experience pain, and the provision of analgesia is an essential component of intensive care unit (ICU) care. Opioids are the mainstay of pain management in the ICU but are limited by their adverse effects, risk of addiction and abuse, and recent drug shortages of injectable formulations. A multimodal analgesia approach, utilizing nonopioid analgesics as adjuncts to opioid therapy, is recommended since they may modulate the pain response and reduce opioid requirements by acting on multiple pain mediators. Nonopioid analgesics discussed in detail in this article are acetaminophen, α-2 receptor agonists, gabapentinoids, ketamine, lidocaine, and nonsteroidal anti-inflammatory drugs. This literature review describes the clinical pharmacology, supportive ICU and relevant non-ICU data, and practical considerations associated with the administration of nonopioid analgesics in critically ill adult patients.

Keywords: ICU; analgesia; critical care; nonopioid; pain management.

MeSH terms

  • Acetaminophen / therapeutic use
  • Adrenergic alpha-2 Receptor Agonists / therapeutic use
  • Adult
  • Analgesia
  • Analgesics / therapeutic use
  • Analgesics, Non-Narcotic / therapeutic use*
  • Analgesics, Opioid / adverse effects
  • Anesthetics, Local / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Critical Care
  • Critical Illness / therapy*
  • Gabapentin / therapeutic use
  • Humans
  • Ketamine / therapeutic use
  • Lidocaine / therapeutic use
  • Pain / drug therapy*
  • Pain Management
  • Pain Measurement

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Analgesics
  • Analgesics, Non-Narcotic
  • Analgesics, Opioid
  • Anesthetics, Local
  • Anti-Inflammatory Agents, Non-Steroidal
  • Acetaminophen
  • Ketamine
  • Gabapentin
  • Lidocaine